NO-1886
CAS: 133208-93-2
Ref. 3D-IFA20893
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- 4-[N-(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonic acid diethyl ester
- Diethyl [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]phosphonate
- Diethyl {4-[(4-Bromo-2-Cyanophenyl)Carbamoyl]Benzyl}Phosphonate
- Ibrolipim
- No-1886
- Opf-009
- Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester
NO-1886 is a novel small molecule that inhibits the activity of growth factor-β1 and is used to treat metabolic disorders, such as bowel disease. It has been shown to increase the expression of lipoprotein lipase in human serum and adipose tissue. NO-1886 also reduces hepatic steatosis and tubulointerstitial injury by inhibiting lipolysis, which prevents the release of fatty acids from adipose tissue into the blood stream. This drug is being developed for clinical trials for the treatment of atherosclerotic lesions.
Propiedades químicas
Consulta técnica sobre: 3D-IFA20893 NO-1886
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
